Three Vanderbilt technologies earned patent protection in July

• 
• 
• 
• 

Three Vanderbilt technologies earned patent protection in July. All three are new technologies from the Vanderbilt Center for Neuroscience Drug Discovery.

9,090,632             Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mGluR5 receptors

9,085,562             6-alkyl-N-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same

9,073,935             Substituted benzylspiroindolin-2-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M1